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The current paper investigated the potential beneﬁt of the traditional Mexican medicinal plant Laennecia confusa (Cronquist) G.
L. Nesom (Asteraceae). Fractions from the hexane, chloroform, methanol, and aqueous extracts were analyzed for antibacterial,
antifungal, anti-inﬂammatory, and antiparasitic activities. The antimicrobial activity of the extracts and fractions was assessed on
bacterial and fungal strains, in addition to the protozoa Leishmania donovani, using a microdilution assay. The propensity of the
plant’s compounds to produce adverse eﬀects on human health was also evaluated using propidium iodine to identify damage
to human macrophages. The anti-inﬂammatory activity of the extracts and fractions was investigated by measuring the secretion
of interleukin-6. Chemical analyses demonstrated the presence of ﬂavonoids, cyanogenic and cardiotonic glycosides, saponins,
sesquiterpenelactones,andtriterpenesinthechloroformextract.Anumberofextractsandfractionsshowantibacterialactivity.Of
particular interest is antibacterial activity against Staphylococcus aureus and its relative methicillin-resistant strain, MRSA. Hexanic
and chloroformic fractions also exhibit antifungal activity and two extracts and the fraction CE 2 antiparasitic activity against
Leishmania donovani. All bioactive extracts and fractions assayed were also found to be cytotoxic to macrophages. In addition, the
hexane and methane extracts show anti-inﬂammatory activity by suppressing the secretion of interleukine-6.
1.Introduction
Ethnomedicine can be documented as far back as the Middle
Paleolithic age, some 60,000 years ago [1]. Several years ago,
the WHO Traditional Medicine Programme identiﬁed a
total of 122 plant-derived compounds employed clinically,
demonstrating the value of plants in drug discovery [1]. Still
much of the vast body of knowledge in traditional medicine
remains unexplored in regards to drug development.
The genus Conyza (Asteraceae) is comprised of approx-
imately 400 species [2], and several species are known for
their use in traditional medicine. Conyza blinii is used in
Chinese folk medicine to treat gastroenteritis, chronic bron-
chitis, and other inﬂammatory diseases [3]. C. canadensis, C.
albida, C. bonariensis, and C. dioscoridis also exhibit antiin-
ﬂammatory, antidiarrhoeal, antimicrobial, antiparasitic, an-
tinociceptive, antioxidant, and expectorant activities as well
as antiaggregatory eﬀects on blood platelets and the inhibi-
tion of catecholamine secretion [2, 4–11].
Currently, there are a number of bioactive compounds,
namely, alkenynes, terpenoids, terpenes, saponins, ﬂavonoi-
ds, sterols, phenylpropanoyl esters, lactones, tannins, and co-
umarins, which have been isolated from the Conyza genus
[3–5, 8, 9, 11–16].
Several epithets of the Conyza genus have been recently
transferred to the genus Laennecia [15]. One such a transfer
is Laennecia confusa (Cronquist) G. L. Nesom [17], a native
Mexican plant found between the states of Chihuahua and2 The Scientiﬁc World Journal
Chiapas. It grows preferentially at a range of 2550–3200m
a b o v es e al e v e li nc o n i f e ra n dQuercus forests [18]. L. confusa
ispreparedasasteminfusionandusedinMexicanfolkmedi-
cine as a sedative and treatment for alcoholic addiction [19].
BecauseofthetraditionaluseofL.confusaandthetaxonomi-
cally close resemblance to other Conyza species exhibiting
other bioactivities, the pharmacological potential of the
plant’s extracts was investigated. In the current study, we ev-
aluated the presence of antimicrobial components in extracts
and fractions obtained from the stems of L. confusa. In addi-
tion, we tested its anti-inﬂammatory, antiparasitic, and cyto-
toxic activities to evaluate and expand its potential use.
2.MaterialsandMethods
2.1. Plant Material. Commercially available L. confusa was
purchased from a herb shop at Puebla, M´ exico. Plants were
collected at Atlixco, Puebla, M´ exico, in January 2008, and
were analyzed by Carlos Mar´ ın Mart´ ınez at the Centro Bot´ a-
nico de Plantas Medicinales, Puebla, M´ exico.
2.2.PreparationofPlantExtracts. Atotalof200gofair-dried
aerial parts of L. confusa were sequentially extracted with n-
hexane (hexane), chloroform, and methanol, after macerat-
ing the material in each solvent in three rounds for 48h at
room temperature. To simulate a herb infusion (according
to the traditional preparation), an aqueous extraction was
carried out by soaking 200g of the same plant material
in boiled distilled water for 2h. Following ﬁltering, solvent
volatilization, and lyophilization (for aqueous extract), the
extracts were chromatographed on silica gel (70–230 mesh)
using approximately 300mL of pure or combined solvents
according to Figure 1. Fractions were dried in a vacuum
using a Rotavapor and stock solutions were prepared by
dissolving 20mg of each fraction in 100µLD M S O( o r
equivalent to obtain the same ﬁnal amount), following
sonication (Branson 3210) for 60min at 30◦C until the
material was completely dissolved.
2.3. Chemical Analysis of the Extracts. Triterpenes, Saponins,
Flavonoids, and Tannins. The presence of triterpenes was det-
ermined by dissolving 10mg of the CEE in 1mL chloroform.
The solution was supplemented with 1mL of acetic anhy-
dride and 2 drops of H2SO4. The appearance of red, pink,
green, purple, or blue coloration in the interface indicates
the presence of triterpenes [20]. Two diﬀerent methods were
used to determine the presence of saponins. In the ﬁrst one,
10mg of CEE was mixed with hot water and the mixture
was shaken for 30sec. The formation of stable foam indicates
the presence of saponins. In the second method, a drop of
Rosenthaler reagent (1g of potassium arsenate dissolved in
100g H2SO4) was added to 10mg CEE. The appearance of
violet coloration indicates the presence of saponins [20]. The
presenceofﬂavonoidswasevaluatedusingtwomethods.The
ﬁrst method was performed by adding 100mg of zinc or
magnesium powder to 10mg of CEE and three drops of HCl.
The appearance of red coloration indicates the presence of
ﬂavonoids [20]. In the second method, three drops of NaOH
were added to 10mg of CEE, and the appearance of yellow
or orange colour indicates the presence of ﬂavonoids [20].
Tannins were determined by preparing a chloroformic solu-
tion of 10mg of CEE. The mixture was ﬁltrated and separat-
ed in two portions. The presence of tannins was evaluated by
the formation of a precipitate by adding either 100mg FeCl3
or gelatine reagent ((1% gelatine (w/v)) [20].
Cardiotonic Glucoside, Sesquiterpene Lactones, Alkaloids,
Cyanogenic Glycosides, and Anthraquinones. Two methods
were used to determine the presence of cardiotonic gluco-
sides and sesquiterpene lactones. In the ﬁrst method, 10mg
of CEE was dissolved in 1mL chloroform. Three drops of
Baljet reagent (1% ethanolic solution of picric acid and 10%
aqueous solution of NaOH) were added [20]. Formation of
red or orange coloration indicates the presence of these com-
pounds. In the second method, 10mg of CEE was dissolved
in 1mL chloroform. Three drops of pyridine, one drop
of 5% sodium nitroprusside, and three drops of 10%
aqueous solution of NaOH were added sequentially. Red
coloration indicates the presence of cardiotonic glucosides
and sesquiterpene lactones. Alkaloids were determined by
preparing a solution of 10mg of CEE dissolved in 5% HCl.
T h er e a g e n t so fM a y e r ,D r a g e n d o r ﬀ,a n dW a g n e rw e r eu s e d
to determine the presence of these compounds [20]. Cyano-
genic glycosides were measured by dissolving 10mg of CEE
in 5 drops of chloroform in a 5mL glass tube. A piece of
ﬁlter paper was impregnated with Grignard reagent (100mg
Na2CO3, 10mg picric acid in 10mL distilled water) and
placed on top of the tube. The appearance of a pink or red
colorafterheatingthesolutionat35◦Cindicatesthepresence
of these compounds [20].
Anthraquinones and Steroids.T h eB o r n t r a g e rr e a c t i o n
was used to detect the presence of anthraquinones. 300mg
of the plant was pulverized for 5min in presence of 10mL of
0.5NK OHand1mLof6%H 2O2 and ﬁltrated. The ﬁltrate
was acidiﬁed with 10 drops of acetic acid and extracted with
10mL benzene. The organic phase was separated and mixed
with2.5mLofNH4OH.Aredcolorinthealkalinelayerindi-
cates the presence of anthraquinones [20] .T h ep r e s e n c eo f
steroids was detected by the appearance of green, blue, pink,
or purple colors after mixing 300mg of the pulverized plant
with 0.5mL acetic anhydride and 2 drops of H2SO4 [20].
2.4. Strains and Culture Media. The bacterial strains used
in this study included the Gram-negative strains Acinetobac-
ter baumannii (ATCC BAA-747), Escherichia coli (ATCC
25922), Pseudomonas aeruginosa (ATCC 14210), and Klebsie-
lla pneumoniae (ATCC 8044). Bacillus subtilis (ATCC 6633),
Mycobacterium smegmatis mc2155 (ATCC 700084), Staphy-
lococcus aureus (ATCC 25923), Methicillin-Resistant Staphy-
lococcus aureus (MRSA) (ATCC 700698), and Streptococcus
pyogenes (ATCC 51878) were used as representatives of
Gram-positive bacteria. Aspergillus fumigatus (ATCC 1022),
Candida albicans (provided by Vancouver General Hospital,
BC, Canada), Cryptococcus neoformans var. grubii (kindly
provided by Dr. Karen Bartlet, University of British Columb-
ia, BC, Canada), and Trichophyton rubrum (ATCC 18758)
were tested as representatives of pathogenic fungi. The
parasite Leishmania donovani Sudan strain 2S was assessedThe Scientiﬁc World Journal 3
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Figure 1: Diagram showing the fractionation of the hexane, chloroform, methanol, and aqueous extracts extracted from the aerial parts of
Laennecia confusa. Ratios of the combined solvents are expressed in volume/volume.
for antiparasitic activity of the extracts and was generously
provided by Dr. Neil Reiner (University of British Columbia,
Vancouver, BC, Canada).
Bacterial strains were cultured in Mueller-Hinton broth
(B&D) except for Mycobacterium smegmatis, which was
cultured in Trypticase Soy broth (B&D). Bacterial stocks
weremaintained onthesamebrothsupplementedwith1.5%
agar (B&D) at 4◦C. All the bacterial strains were cultured
at 37◦C. Fungi were cultured in Sabouraud broth (B&D),
and the antifungal activity against ﬁlamentous fungi was
assessed from spores. Speciﬁcally, spores of A. fumigatus and
T. rubrum were incubated at 28◦C until sporulation. Spores
were harvested by carefully rubbing the top of sporulated
colonies in 2mL Sabouraud broth containing 10% glycerol.
Spores were aliquoted and kept at −20◦C. For C. albicans
and C. neoformans, the same protocol used for bacterial
strains was followed, but using Sabouraud broth L. donovani
promastigoteswereculturedinmediumM199supplemented
with 10% fetal bovine serum (Gibco), 1% penicillin and
streptomycin, 20mmol/l Hepes (Stem Cell Technologies),
6µg/mL hemin, 2mmol/L L-glutamine, 10µg/mL folic acid,
and 100µmol/L adenosine at 26◦C in a EchoTherm Chilling4 The Scientiﬁc World Journal
Incubator (Torrey Pines Scientiﬁc, San Marcos, CA, USA).
Every third day the organisms were split 1:10 into fresh
medium.
2.5. Antimicrobial and Antiparasitic Assays. A microdilution
assay was used to assess the antimicrobial activities using
a 96-well plate and according to published protocols [21].
Bacterial strains were grown overnight by shaking at 37◦C.
The next day, the inoculum density for the bacterial strains
was adjusted to 0.5 on the McFarland scale [22] with an opti-
cal density of 0.080–0.100 at 625nm. Extracts and fractions
at concentrations of 2, 20, 30, 50, 100, 200, 500, 1000, and
2000µg/mL were evaluated in a ﬁnal volume of 150µL/well.
Minimal inhibitory concentrations (MICs) were determined
by incubating the organisms in 96-well microplates for 24h
at 37◦C. Endpoints were determined when no turbidity in
the well was observed. DMSO and untreated inoculum were
used as negative controls, while gentamicin was used as
a positive control. Antifungal properties were evaluated in
RPMI 1640 medium supplemented with L-glutamine with-
out NaHCO3 (Gibco). Fungal strains were grown at 28◦C
for 24h using the same 96-well format, and in the case of T.
rubrum and A. fumigatus, plates were incubated at the same
temperature but for a period of 72h. DMSO and untreated
i n o c u l u mw e r eu s e da sn e g a t i v ec o n t r o l s ,w h i l eﬂ u c o n a z o l e
and amphotericin B were used as positive controls.
The evaluation of antiparasitic activity was performed
in 24-well ﬂat bottom plates containing 1 × 106 promastig-
otes/well. Compounds were evaluated at a ﬁnal concentra-
tion of 0.02, 0.2, and 2mg/mL. Untreated parasites and
DMSO were used as negative controls. Motility and number
of parasites were registered at 24, 48, and 72h, after staining
the sample with 1% Trypan blue solution. Only bioactive ex-
tracts and fractions are shown.
2.6. Cytotoxicity Assays. The human-derived monocytic cell
line THP-1 (ATCC 202) was cultured in RPMI 1640 (Hyclo-
ne) supplemented with 5% fetal calf serum (FCS) (Hyclone),
and 2mM L-glutamine (Stem Cell Technologies). THP-1
cells were dispensed at a concentration of 3 × 105/well in a
96-well plate and incubated with compound concentrations
that showed antibacterial or antifungal activity. Plates were
placed at 37◦C in a humidiﬁed atmosphere supplemented
with 5% CO2 for 24h. Nontreated THP-1 cells or DMSO
were used as negative controls. THP-1 cells exposed to 5%
hydrogen peroxide were used as a positive control. Propidi-
um iodide (PI) was used to evaluate cell damage according to
published procedures [23]. Results are presented as percent-
age of the distribution area as calculated by the Flow Cyto-
meter software.
2.7. Anti-Inﬂammatory Assay. The anti-inﬂammatory activ-
ities of the extracts were studied in vitro by measuring the
secretion of the proinﬂammatory interleukin 6 (IL-6) from
THP-1 cells. THP-1 cells were seeded at a concentration of
3 × 105/well in a 96-well plate. Monocytes were cultured as
described previously. Before the induction of an inﬂamma-
tory process, cells were incubated with 20µg/mL HEE, CEE,
MEE, or AEE for 5h at 37◦C supplemented with 5% CO2.
DMSOwasusedasanegativecontrol.Next,aninﬂammatory
process was induced by addition of 50µL lipopolysaccharide
(LPS) (Sigma) at a ﬁnal concentration of 100ng/mL after
washing the cells with fresh RPMI medium (x3). After 3h
ofincubation, thesupernatantsweretransferredtoanew96-
wellplateandstoredat−20◦Cforfurtherprocessing.Asand-
wichELISAwasusedtoevaluatethesecretionofIL-6accord-
ing to published protocols [24]. Human anti-IL-6 antibody
(RD Systems) was used as primary antibody, while a mix-
ture of biotinylated human anti-IL-6 diluted 1:6000 (RD
Systems) and goat HRP-anti-biotin diluted 1:250 (RD Sys-
tems)wasusedasasecondaryantibody.3,3 ,5,5  tetramethy-
lbenzidine was used as a developer, and reactions were
stopped with 25µL of 1M sulphuric acid. Plates were read
immediately in an ELISA plate reader using a 450nm ﬁlter.
Thecommercialavailablesteroidsprednisoloneanddexame-
thasone (Sigma) were used as positive controls. Nontreated
macrophages were used as a negative control. Experiments
were performed in triplicate.
2.8. Statistical Analysis. A Mann-Whitney test was used for
statistical analysis. A P value < 0.05 was considered signi-
ﬁcant.
3. Results
3.1.ChemicalConstituentsoftheExtracts. Thehexane,chlor-
oform, methanol, and aqueous extracts (HEE, CEE, MEE,
and AEE, resp.) yielded 1.92g (0.96%), 2.96g (1.48%),
21.36g (10.68%), and 24.46g (12.23%) of residue, respec-
tively.Atotalof71fractionscorrespondingtothehexane,ch-
loroform,methanol,andaqueousextractswerecollectedand
combined according to their TLC proﬁle. Eight hexanic frac-
tions, eight chloroformic fractions, ten methanolic fractions,
and nine aqueous fractions were obtained. The correspond-
ing weight of each fraction is listed in Figure 1. Chemical
analyses of the CEE show the presence of ﬂavonoids, cyanog-
enicandcardiotonicglycosides,saponins,sesquiterpenelact-
ones,andtriterpenes(datanotshown).Noalkaloids,anthra-
quinones, steroids, or tannins were detected in the assayed
extract.
3.2. Antibacterial Activity. L. confusa HEE, CEE, and MEE
were analyzed for their antibacterial activity against several
Gram-negative and Gram-positive strains. The chloroformic
and methanolic fractions CE 4 and ME 3 inhibited the
growth of K. pneumoniae at concentrations of 1000µg/mL,
whereas the methanolic fraction ME 4 inhibited the growth
of both E. coli and P. aeruginosa at the same concentration
(Table 1). No activity against the Gram-negative strains was
observed when any of the extracts were evaluated. Growth
inhibition was also observed in two of the Gram-positive
bacteria, MRSA and S. aureus. Two hexanic (HE 1, HE
3), two chloroformic (CE 3, CE 4), and three methanolic
(ME 3, ME 4, ME 5) fractions were determined to possess
antibacterial activity against MRSA at ﬁnal concentrations of
200 or 1000µg/mL (Table 1), while S. aureus was inhibitedThe Scientiﬁc World Journal 5
Table 1: Antimicrobial activity of extracts and fractions of
Laennecia confusa expressed as MIC (µg/mL).
Bacteria Fungi
EC KP MRSA PA SA CA CN TR
HE 1 NA NA 1000 NA 1000 NA NA NA
HE 3 NA NA 1000 NA 1000 1000 NA 100
HE 4 NA NA NA NA NA 1000 200 30
HE 8 NA NA NA NA NA 1000 1000 100
CEE NA NA NA NA 1000 NA NA NA
CE 1 NA NA NA NA NA 1000 NA NA
CE 2 NA NA NA NA NA 1000 NA NA
CE 3 NA NA 1000 NA NA 100 NA 50
CE 4 NA 1000 200 NA NA 1000 1000 NA
ME 3 NA 1000 200 NA 1000 NA NA NA
ME 4 1000 1000 1000 1000 NA NA NA NA
ME 5 NA NA 1000 NA NA NA NA NA
EC: Escherichia coli;K P :Klebsiella pneumoniae; MRSA: methicillin-resistant
Staphylococcus aureus;P A :Pseudomonas aeruginosa;S A :Staphylococcus
aureus;C A :Candida albicans;C N :Cryptococcus neoformans;T R :Tri-
chophyton rubrum. NA: no activity detected; CEE: chloroform extract; HE:
hexanic fractions; CE: chloroformic fractions; ME: methanolic fractions.
Experiments were performed in triplicate.
by the same hexanic fractions and the ME 3 fraction at
the same concentrations. Growth inhibition of S. aureus
was also observed by the CEE extract at a concentration of
1000µg/mL (Table 1), suggesting the presence of antibac-
terial compound(s) against staphylococcal strains. No bioac-
tivity was observed in the solvent control.
3.3. Antifungal Activity. Three out of four fungal strains as-
sayed were inhibited by at least one of the fractions analyzed.
Three hexanic fractions (HE 3, HE 4, HE 8) and the same
number of chloroformic (CE 1, CE 2, CE 3) fractions
show activity against Candida albicans at concentrations of
1000µg/mL, while the same hexanic fractions and the chlor-
oformic fraction CE 3 inhibited the grow of C. neoformans at
concentrations of 200 or 1000µg/mL. Spore growth inhibi-
tion of T. rubrum occurred at MICs varying from 30 to
100µg/mL of the hexanic fractions (HE 3, HE 4, HE 8)
(Table 1). No bioactivity was observed in the solvent control.
No antifungal activities were detected against A. fumigatus.
3.4. Antiparasitic Activity. A reduction in growth of L. do-
novani in comparison to the controls from the aqueous and
chloroform extracts and the chloroformic fraction CE 2 was
observed in the antiparasitic assay. A decrease of approxi-
mately 50% in the number of parasites was measured after
72h after exposure of the tested compounds (Figure 2).
IC50 values of 20µg/mL were calculated for both aqueous
and chloroform extracts, whereas an IC50 of 200µg/mL was
measured for the chloroformic fraction CE 2 (Figure 2).
3.5. Cytotoxic Activity. T h ee x t r a c t sa n df r a c t i o n sd e m o n -
strating antiparasitic activity in the previous assay were
0 24 48 72
0
50
100
150
200
CE 2
Control
DMSO
AEE
CEE
Time (h)
C
e
l
l
 
n
u
m
b
e
r
 
(
×
1
0
4
/
m
L
)
∗
Figure 2: Antiparasitic activity exhibited by fractions of Laennecia
confusa. Leishmania donovani promastigote growth inhibition was
evaluated after incubation of the parasites with the compounds.
UntreatedpromastigotesandDMSOwereusedasnegativecontrols.
Control: untreated promastigotes. Shown is the mean ± SD of three
independent experiments. ∗P value < 0.0001.
incubated with the human-derived monocyte THP-1 cells to
determinetheircytotoxiceﬀects.Following24hexposure,all
of the tested compounds exhibited toxicity to macrophages
(Figure 3(a)) with calculated IC50 (±SD) values of 24.8
± 1.89, 25 ± 2.35, and 24.2 ± 1.23µg/mL for the AEE
and CEE and the chloroformic fraction CE 2, respectively
(Figure 3(b)).
3.6. Anti-Inﬂammatory Activity. Human-derived macropha-
ges were exposed to each of the extracts and then an inﬂam-
matory response was induced with LPS. To evaluate the
inﬂammatoryresponse,thesecretionofthepro-andanti-in-
ﬂammatory IL-6 cytokine was measured in the supernatant
of the cultures. A concentration of 580pg/mL of IL-6 was
measuredin the supernatantwhenLPSwasadded to the ma-
crophages, while levels of 233 and 251pg/mL were measured
w h e nt h e s ec e l l sw e r ep r e t r e a t e dw i t hH E Ea n dM E E ,
respectively (Figure 4) .T h e s ev a l u e sr e p r e s e n tar e d u c t i o no f
approximately 60% in the secretion of IL-6. Similar results
were measured when macrophages were exposed to predni-
solone or dexamethasone, suggesting both extracts contains
anti-inﬂammatory compounds. No eﬀects were observed
when either the CEE or AEE was supplemented to the cult-
ures.
4. Discussion
Several species from the Conyza (Laennecia) genus are used
in traditional medicine for the treatment of inﬂammatory
and infectious ailments [8]. Previous studies [3, 5, 10]h a v e
conﬁrmed bioactive properties for speciﬁc Conyza species,
triggering further interest in Conyza-derived drug discovery.
The chemical investigation of L. confusa revealed a close6 The Scientiﬁc World Journal
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Figure 3: Cytotoxic eﬀects of compounds from Laennecia confusa.
(a) THP-1 cells were used to assess the cytotoxic eﬀects of bioactive
compounds using propidium iodine staining and the obtained
values were used to calculate the IC50 (b). Dashed lines represent
treatment with 5% H2O2 (upper line) (positive control) and
untreated cells (lower line) (negative control). Shown is the mean
± SD of three independent experiments. CE is a chloroformic
fraction, and AEE and CEE are aqueous and chloroform extracts,
respectively. ∗P value < 0.0001.
chemical resemblance to several Conyza (Laennecia)s p e c i e s
leading to the exploration of the plant’s antimicrobial, anti-
parasitic, and anti-inﬂammatory properties in this study.
The current study shows that extracts and fractions from
L. confusa possess antimicrobial activity against both Gram-
negativeandGram-positive organisms.Particularly,themaj-
ority of antibacterial is conﬁned to S. aureus and its methi-
cillin-resistant counterpart. These ﬁndings are of particular
importance due to increasing resistance of MRSAs to beta-
lactam antibiotics rendering the infection diﬃcult to treat
using current methods [25]. L. confusa fractions also show
antibacterial activity against the Gram-negative strains E.
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Figure 4: Anti-inﬂammatory activity of extracts and fractions
from Laennecia confusa. An inﬂammatory process was elicited by
exposing macrophages to LPS. Crude extracts were exposed to
macrophages before the addition of LPS. The anti-inﬂammatory
process was evaluated by measuring the secretion of IL-6 into the
supernatant. Shown is the mean ± SD of three independent ex-
periments. Numbers on the bars indicate the concentration of IL-
6 in pg/mL. HEE, CEE, MEE, and AEE are hexane, chloroform,
methanol, and aqueous extracts, respectively.
∗P value < 0.0001.
coli, K. pneumonia,a n dP. aeruginosa. Our results are in line
with those reported for other Conyza species. For instance,
the compounds conyzolide, conyzoﬂavone, and 8R,9 R-dihy-
droxymatricarine methyl ester isolated from C. canazdensis
were active against S. aureus and E. coli [9, 11, 26].
A number of fractions and extracts were also found to
have antifungal activity against yeast-like strains C. albicans,
and C. neoformans, and against the ﬁlamentous T. rub-
rum. The ﬂavones, glycolides, glycosides, steroids and triter-
penoidsisolatedfromConzyaspecies’extractsarereportedto
possess comparable antifungal properties against these and
additional fungi such as Fusarium solani and Microsporum
gypsum [9, 26].
Antiprotozoal activity of the fractions and extracts was
also assessed against L. donovani. A fraction of the CEE, CE
2, and the CEE and AEE display strong inhibitory eﬀects on
growth following 48h of incubation. Similar values of IC50
ranging between 2 and 70µg/mL inhibiting the growth of
Plasmodium falciparum were reported using extracts of C.
albida, C. podocephala,a n dC. scabrida [6]. Moreover, ex-
tracts from C. ﬁlaginoides showed IC50 values ranging be-
tween 14–119 and 15–178µg/mL against Entamoeba histolyt-
ica,a n dGiardia lamblia,r e s p e c t i v e l y[ 3].
The AEE, CEE, and the chloroformic fraction CE 2
demonstrated that antiparasitic activity was further analyzed
for their cytotoxicity against macrophages. Although the PI
assay identiﬁed all of the samples analyzed as cytotoxic to
macrophages, these extracts can still be developed for top-
ical applications, such as antimicrobial and antileishmanial
formulations. Other studies reported that an AEE of ConyzaThe Scientiﬁc World Journal 7
bonariensis also showed cytotoxicity with the brine shrimp
(Artemia ssp.) toxicity test [13]. Moreover, four compounds
isolated from C. albida exhibited cytotoxic activities against
the tumor KB cell line at concentrations of 7–19µg/mL [13].
Finally, the ability of HEE and MEE from L. confusa
to decrease the inﬂammatory response elicited by LPS is in
agreement with other anti-inﬂammatory activities reported
for L. sophiifolia in a carrageenan-induced paw oedema in
mice [12].
5. Conclusion
The extracts and fractions from the plant species L. confusa
represent a new, valuable source of antimicrobial agents
against bacterial, fungal, and parasitic pathogens. Of special
interest is the potency of two fractions from the CEE (CE
4) and MEE (ME 3), which show strong anti-MRSA activity.
Moreover, three fractions from the HEE (HE 3, HE 4, HE
8) show antimycotic activity against the pathogens C. neofor-
mans and T. rubrum. We also show that AEE and CEE, as
well as the chloroformic fraction CE 2, were eﬀective as anti-
leishmanial agents, and HEE and MEE signiﬁcantly reduce
the secretion of IL-6, a cytokine involved in the progression
of inﬂammatory processes.
Although, in its native Mexican growth area, L. confusa is
only used in folk medicine as a sedative and to treat addic-
tions, in this paper we provide evidence that L. confusa pos-
sesses antimicrobial, antiparasitic, and anti-inﬂammatory
bioactivities similar to those previously reported for the gen-
us Conyza. Our study supports the fact that this plant can
potentially be used for the treatment of other illnesses out-
side its current use in folk medicine. Although the extracts
and fractions obtained from this plant have shown cytotoxic
eﬀects against human cells, it could still be useful in topical
formulations for the treatment of skin infection caused by
S. aureus in both humans and animals. Moreover, although
this work intended to screen the bioactivities using a cell
line model, studies of the bioactivities using a murine model
would be advantageous to demonstrate the bioactivities in
vivo. Future research is required to identify and isolate the
plant’s bioactive compounds to assess its potential as a
candidate for drug discovery programs.
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